List of Celldex Therapeutics patents

List of Celldex Therapeutics patents

List of Enzon Pharmaceuticals patents

List of Southco patents

List of Minebea patents

List of companies in Heilemann Ventures's investment portfolio

Companies in the Propulsion industry

Patents where

Current Assignee

Name

is

Celldex Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10184007 Methods of treating a kit-associated cancer by administering anti-kit antibodies	Patent 10184007 was granted and assigned to Celldex Therapeutics on January, 2019 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	10184007	January 22, 2019
	‌ US Patent 10189907 Polynucleotides encoding anti-KIT antibodies	Patent 10189907 was granted and assigned to Celldex Therapeutics on January, 2019 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	10189907	January 29, 2019
	‌ US Patent 9605081 Polynucleotides encoding anti-kit antibodies	Patent 9605081 was granted and assigned to Celldex Therapeutics on March, 2017 by the United States Patent and Trademark Office.	‌ Kolltan Pharmaceuticals, Inc.	Celldex Therapeutics		United States Patent and Trademark Office	9605081	March 28, 2017
	‌ US Patent 11332537 Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs		Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	11332537	May 17, 2022
	‌ US Patent 11459393 Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs		Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	11459393	October 4, 2022
	‌ US Patent 10239943 Treatment of eosinophil or mast cell related disorders	Patent 10239943 was granted and assigned to Celldex Therapeutics on March, 2019 by the United States Patent and Trademark Office.	‌ Kolltan Pharmaceuticals, Inc.	Celldex Therapeutics		United States Patent and Trademark Office	10239943	March 26, 2019
	‌ US Patent 10941201 Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies	Patent 10941201 was granted and assigned to Celldex Therapeutics on March, 2021 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	10941201	March 9, 2021
	‌ US Patent 11180566 Antibodies that bind human CD27 and uses thereof	Patent 11180566 was granted and assigned to Celldex Therapeutics on November, 2021 by the United States Patent and Trademark Office.		Celldex Therapeutics		United States Patent and Trademark Office	11180566	November 23, 2021
	‌ US Patent 10793639 Methods of treating by administering anti-kit antibodies	Patent 10793639 was granted and assigned to Celldex Therapeutics on October, 2020 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	10793639	October 6, 2020
	‌ US Patent 10781267 Methods of treating by administering anti-kit antibodies	Patent 10781267 was granted and assigned to Celldex Therapeutics on September, 2020 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	10781267	September 22, 2020
	‌ US Patent 10774146 Treatment of eosinophil or mast cell related disorders	Patent 10774146 was granted and assigned to Celldex Therapeutics on September, 2020 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	10774146	September 15, 2020
	‌ US Patent 11091559 Anti-ALK antibodies and methods for use thereof	Patent 11091559 was granted and assigned to Celldex Therapeutics on August, 2021 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	11091559	August 17, 2021
	‌ US Patent 10633444 Agonistic antibodies that bind CD40		Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	10633444	April 28, 2020
	‌ US Patent 10865244 Nucleic acids encoding agonistic antibodies that bind CD40			Celldex Therapeutics		United States Patent and Trademark Office	10865244	December 15, 2020
	‌ US Patent 9051615 Method of detecting and treating tuberous sclerosis complex associated disorders	Patent 9051615 was granted and assigned to Celldex Therapeutics on June, 2015 by the United States Patent and Trademark Office.		Celldex Therapeutics		United States Patent and Trademark Office	9051615	June 9, 2015
	‌ US Patent 11987626 Treatment of eosinophil or mast cell related disorders	Patent 11987626 was granted and assigned to Celldex Therapeutics on May, 2024 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	11987626	May 21, 2024
	‌ US Patent 11884734 Anti-MET antibodies and methods of use thereof	Patent 11884734 was granted and assigned to Celldex Therapeutics on January, 2024 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	11884734	January 30, 2024
	‌ US Patent 11884699 Anti-KIT antibodies and uses thereof	Patent 11884699 was granted and assigned to Celldex Therapeutics on January, 2024 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	11884699	January 30, 2024
	‌ US Patent 11891452 Anti-kit antibodies and uses thereof	Patent 11891452 was granted and assigned to Celldex Therapeutics on February, 2024 by the United States Patent and Trademark Office.	Celldex Therapeutics	Celldex Therapeutics		United States Patent and Trademark Office	11891452	February 6, 2024

19 results

0 selected

19 results

0 selected